Italia markets open in 5 hours 50 minutes

Ovid Therapeutics Inc. (1OT.F)

Frankfurt - Frankfurt Prezzo differito. Valuta in EUR.
Aggiungi a watchlist
2,9000-0,0600 (-2,03%)
Alla chiusura: 08:15AM CEST
Schermo intero
Chiusura precedente2,9600
Aperto2,9000
Denaro2,7800 x 0
Lettera2,8400 x 0
Min-Max giorno2,9000 - 2,9000
Intervallo di 52 settimane2,4600 - 3,6800
Volume1.000
Media Volume16
Capitalizzazione205,059M
Beta (5 anni mensile)0,69
Rapporto PE (ttm)N/D
EPS (ttm)-0,6900
Prossima data utili03 mag 2024 - 07 mag 2024
Rendimento e dividendo (futuro)N/D (N/D)
Data ex dividendoN/D
Stima target 1A4,75
  • GlobeNewswire

    Ovid Therapeutics to Present at the Jefferies Biotech CNS/Neuro Summit

    NEW YORK, Oct. 10, 2023 (GLOBE NEWSWIRE) -- Ovid Therapeutics Inc. (NASDAQ: OVID), a biopharmaceutical company committed to developing medicines that transform the lives of people with epilepsies and seizure-related disorders, today announced that management will participate in a presentation at the Jefferies Inaugural Biotech CNS/Neuro Summit on Thursday, October 12, 2023, at 3:30 p.m. ET in New York. A live webcast of the Jefferies presentation can be accessed through the Events & Presentation

  • GlobeNewswire

    Ovid Therapeutics to Host Investor Event - R&D Day on Monday, October 2, 2023

    NEW YORK, Sept. 26, 2023 (GLOBE NEWSWIRE) -- Ovid Therapeutics Inc. (NASDAQ: OVID), a biopharmaceutical company committed to developing medicines that transform the lives of people with epilepsies and seizure-related disorders, today announced that it will host a Research & Development (R&D) Day investor event on Monday, October 2, 2023. The event will take place at the Company’s headquarters in New York’s Hudson Yards from 12:00 pm - 2:30 pm and will be webcast simultaneously. Ovid management w

  • GlobeNewswire

    Ovid Therapeutics to Present at the 2023 Cantor Fitzgerald Global Healthcare Conference

    NEW YORK, Sept. 20, 2023 (GLOBE NEWSWIRE) -- Ovid Therapeutics Inc. (NASDAQ: OVID), a biopharmaceutical company committed to developing medicines that transform the lives of people with epilepsies and seizure-related disorders, today announced that management will participate in a panel presentation at the 2023 Cantor Fitzgerald Global Healthcare Conference on Tuesday, September 26, 2023, at 9:55 a.m. ET in New York, New York. A live webcast of the Cantor Fitzgerald presentation can be accessed